Oxygen free radical scavenger enzyme polymorphisms in systemic sclerosis

Free Radical Biology and Medicine

Volumn 36, Issue 11, 2004, Pages 1403-1407

  Tikly, Mohammed ^a   Marshall, Sara E ^b   Haldar, Neil A ^c   Gulumian, Mary ^d   Wordsworth, Paul ^e   Welsh, Ken I ^f  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d National Centre for Occupational Health   (South Africa)

^e NUFFIELD ORTHOPAEDIC CENTRE   (United Kingdom)

^f NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Africa; Free radicals; Glutathione S transferase; Manganese superoxide dismutase; Scleroderma

Indexed keywords

GLUTATHIONE TRANSFERASE; ISOENZYME; MANGANESE SUPEROXIDE DISMUTASE; OXYGEN; SCAVENGER;

AFRICA; ALLELE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ENZYME POLYMORPHISM; FEMALE; GENE FREQUENCY; HUMAN; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; SYSTEMIC SCLEROSIS;

ALLELES; CASE-CONTROL STUDIES; FEMALE; FREE RADICAL SCAVENGERS; GLUTATHIONE TRANSFERASE; HUMANS; MALE; OXYGEN; PHENOTYPE; POLYMORPHISM, GENETIC; SCLERODERMA, SYSTEMIC; SUPEROXIDE DISMUTASE;

SCLERODERMA;

EID: 2342616691     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2004.02.079     Document Type: Article

References (31)

1. Herrick A.L., Rieley F., Schofield D., Hollis S., Braganza J.M., Jayson M.I.V. Micronutrient antioxidant status in patients with primary Raynaud's phenomenon and systemic sclerosis. J. Rheumatol. 21:1994;1477-1483
2. Belch J.J.F. Raynaud's phenomenon: its relevance to scleroderma. Ann. Rheum. Dis. 50:1991;839-845
3. Murrell D.F. A radical proposal for the pathogenesis of scleroderma. J. Am. Acad. Dermatol. 28:1993;78-85
4. Lundberg A.-C., Åkesson A., Åkesson B. Dietary intake and nutritional status in patients with systemic sclerosis. Ann. Rheum. Dis. 51:1992;1143-1148
5. Seidergard J., Vorachek W.R., Pero R.W., Pearson W.R. Hereditary differences in the expression of the human glutathione S-transferase activity on trans-stilbene oxide are due to a gene deletion. Proc. Natl. Acad. Sci. USA. 85:1988;7293-7297
6. Hayes J.D., Strange R.C. Glutathione S-transferase polymorphisms and their biological consequences. Pharmacology. 61:2000;154-166
7. De Jong J.L., Chang C.M., Whang-Peng J., Knutsen T., Tu C.P. The human liver glutathione S-transferase gene superfamily: expression and chromosome mapping of an Hb subunit cDNA. Nucleic Acids Res. 16:1988;8541-8554
8. Pemble S., Schroeder D.R., Spencer S.R., Meyer D.J., Hallier E., Bolt H.M., Ketterer B., Taylor J.B. Human glutathione S-transferase theta (GSTT1): cDNA clonong and the characterisation of a genetic polymorphism. Biochem J. 300:1994;271-276
9. Watson M.A., Stewart R.K., Smith G.B.J., Massey T.E., Bell D.A. Human glutathione S-transferase P1 polymorphisms: relationship to lung tissue enzyme activity and population frequency distribution. Carcinogenesis. 19:1998;275-280
10. Ryberg D., Skaug V., Hewer A., Phillips D.H., Harries L.W., Wolf C.R., Øgreid D., Ulvik A., Vu P., Haugen A. Genotype of glutathione transferase M1 and P1 and their significance for lung DNA adduct levels and cancer risk. Carcinogenesis. 18:1997;1285-1289
11. Watters J.W., McLeod H.L. Recent advances in the pharmacogenetics of cancer chemotherapy. Curr. Opin. Mol. Ther. 4:2002;565-571
12. Mattey D.L., Hutchinson D., Dawes P.T., Nixon N.B., Clarke S., Fisher J., Brownfield A., Alldersea J., Fryer A.A., Strange R.C. Smoking and disease severity in rheumatoid arthritis: association with polymorphism at the glutathione S-transferase M1 locus. Arthritis Rheum. 46:2002;640-646
13. Morinobu A., Kanagawa S., Koshiba M., Sugai S., Kumagia S. Association of the glutathione S-transferase M1 homozygous null genotype with susceptibility to Sjogren's syndrome in Japanese individuals. Arthritis Rheum. 42:1999;2612-2615
14. Ollier W., Davies E., Snowden N., Alldersea J., Fryer A., Jones P., Strange R. Association of homozygosity for glutathione-S-transferase GSTM1 null alleles with the Ro+/La- autoantibody profile in patients with systemic lupus erythematosus. Arthritis Rheum. 39:1996;1763-1764
15. Tew M.B., Reveille J.D., Arnett F.C., Friedman A.W., McNearney T., Fischbach M., Ahn C., Tan F.K. Glutathione S-transferase genotypes in systemic sclerosis and their association with clinical manifestations in early disease. Genes Immun. 2:2001;236-238
16. Palmer C.N.A., Young V., Ho M., Doney A., Belch J.J.F. Association of common variation in glutathione S-transferase genes with premature development of cardiovascular disease in patients with systemic sclerosis. Arthritis Rheum. 48:2003;854-855
17. Rosenblum J.S., Gilula N.B., Lerner R.A. On signal sequence polymorphisms and diseases of distribution. Proc. Natl. Acad. Sci. USA. 93:1996;4471-4473
18. Shimoda-Matsubayashi S., Matsumine H., Kobayashi T., Nakagawa-Hattori Y., Shimuzu Y., Mizuno Y. Structural dimorphism in the mitochondrial targeting sequence in the human manganese superoxide dismutase gene. Biochem. Biophys. Res. Commun. 226:1996;561-565
19. Mattey D.L., Hassell A.B., Dawes P.T., Jones P.W., Yengi L., Alldersea J.E., Strange R.C., Fryer A.A. Influence of polymorphism in the manganese superoxide dismutase locus on disease outcome in rheumatoid arthritis: evidence for the interaction with glutathione S-tranferase genes. Arthritis Rheum. 43:2000;859-864
20. Tager R.E., Tikly M. Clinical and laboratory manifestations of systemic sclerosis (scleroderma) in black South Africans. Rheumatology. 38:1999;397-400
21. Jacobsen S., Halberg P., Ullman S., van Venrooij W.J., Hoier-Madsen M., Wiik A. Clinical and serum antinuclear antibodies in 230 Danish patients with systemic sclerosis. Br. J. Rheumatol. 37:1998;39-45
22. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum. 23:1980;581-590
23. LeRoy E.C., Black C., Fleischmajer R., Jablonska S., Krieg T., Medsger T.A. Jr., Rowell N., Wollheim F. Scleroderma (systemic sclerosis): classification, subsets, and pathogenesis. J. Rheumatol. 15:1988;202-205
24. Craft J., Mimori T., Olsen T.L., Hardin J.A. The U2 small ribonucleoprotein particle as an autoantigen. J. Clin. Invest. 81:1988;1716-1724
25. Marshall S.E., Bordea C., Haldar H.A., Mulligan C.G., Wojnarowska F., Morris P.J., Welsh K.I. Glutathione S-transferase polymorphisms and skin cancer after renal transplantation. Kidney Int. 58:2000;2186-2193
26. St Peter S.D., Imber C.J., Jones D.C., Fuggle S.V., Watson C.J., Friend P.J., Marshall S.E. Genetic determinants of delayed graft function after kidney transplantation. Transplantation. 74:2002;809-813
27. Lo Y.-M., Patel P., Newton C.R., Markham A.F., Fleming K.A., Wainscoat J.S. Direct haplotype determination by double ARMS: specificity, sensitivity, and genetic applications. Nucleic Acid Res. 19:1991;3561-3567
28. Mukanganyama S., Masimirembwa C.M., Naik Y.S., Hasler J.A. Phenotyping of the glutathione S-transferase M1 polymorphism in Zimbabweans and the effect of chloroquine on blood glutathione S-transferase M1 and A. Clin. Chim. Acta. 265:1997;145-155
29. Dandara C., Sayi J., Masimirembwa C.M., Magimba A., Kaaya S., De Sommers K., Snyman J.R., Hasler J.A. Genetic polymorphism of cytochrome P450 1A1 (Cyp1A1) and glutathione transferases (M1, T1 and P1) among Africans. Clin. Chem. Lab. Med. 40:2002;952-957
30. Rebbeck T.R. Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol. Biomarkers Prev. 6:1997;733-743
31. Ketterer B., Fraser G., Meyer D.J. Nuclear glutathione transferases which detoxify irradiated DNA. Adv. Exp. Med. Biol. 264:1990;301-310